Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000237987
Ethics application status
Approved
Date submitted
28/02/2011
Date registered
4/03/2011
Date last updated
25/06/2014
Type of registration
Prospectively registered

Titles & IDs
Public title
Comparison of Traditional Landmark versus Ultrasound Guided Placement of Percutaneous Tracheostomies in Adult Intensive Care Patients -­ A Randomised Controlled Trial
Scientific title
Comparison, in adult intensive care patients, of ultrasound guided versus traditional landmark guided placement of percutaneous dilatational tracheostomies to determine effect on tracheostomy position.
Secondary ID [1] 259623 0
None
Universal Trial Number (UTN)
Trial acronym
TARGET Study ­ (Traditional landmArk versus ultRasound Guided Evaluation Trial)
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Positioning of percutaneous tracheostomies in relation to the tracheal midline and cranio-caudal distance from the cricoid cartilage 261182 0
Condition category
Condition code
Respiratory 259336 259336 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Real time ultrasound guidance will be used to determine tracheal midline and cranio-caudal distance (i.e number of tracheal rings) from the cricoid catilage to determine the the site of the tracheal puncture which is the initial step in a percutaneous dilatational tracheostomy. A bronchoscopic image will be taken after the puncture which will be used to evaluate the puncture position during data analysis. After the puncture, insertion of the tracheostomy will proceed as per the routine used for insertion of a percutanous dilatational tracheostomy. The entire procedure is expected to last between 15-30 minutes.
Intervention code [1] 258056 0
Treatment: Devices
Comparator / control treatment
Tracheal puncture will be carried out without the use of ultrasound, as per the traditional landmark technique (i.e using palpation to identify the landmarks and correct position for insertion of the tracheostomy tube). Puncture will be followed by taking of a bronchoscopic image and routine completion of the percutaneous dilatational tracheostomy.The entire procedure is expected to last between 15-30 minutes.
Control group
Active

Outcomes
Primary outcome [1] 262138 0
Deviation from tracheal midline in degrees as measured on bronchoscopic image scaled to standardised size and fitted to a standard protractor.
Timepoint [1] 262138 0
Bronchoscopic image used for evaluation is taken immediately after the tracheal puncture in both groups.
Primary outcome [2] 262139 0
Cranio-caudal distance from cricoid cartilage (i.e number of tracheal cartilage rings between the puncture and the cricoid cartilage) - Outcomes: <1, 1-3, >3
Timepoint [2] 262139 0
Bronchoscopic image used for evaluation is taken immediately after the tracheal puncture in both groups.
Secondary outcome [1] 273220 0
Time to wean from ventilator
Timepoint [1] 273220 0
Time point recorded once patient has been off ventilator for >24hrs
Secondary outcome [2] 273221 0
Infection - tracheostomy site
Timepoint [2] 273221 0
90 days or until decannulated (whichever occurs first)
Secondary outcome [3] 273222 0
Bleeding related to tracheostomy
Timepoint [3] 273222 0
90 days or until decannulated (whichever occurs first)

Eligibility
Key inclusion criteria
All adult intensive care patients where a decision has been made to insert a percutaneous dilatational tracheostomy
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Under 18 years old
Pregnant women

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
All adult intensive care patients where a decision has been made to insert a tracheostomy are potential participants in the study. The decision to insert a tracheostomy lies with the Intensive Care Specialists. All intensive Care Specialists will be aware of the study and the requirement to screen potential participants. It will be part of the study protocol for the Specialist to inform a member of the research team once a decision to insert a tracheostomy has been made. Quite often a potential need for a tracheostomy is realised well before the decision is made to insert one (depending on patient progress, etc) so research staff will also regularly contact Staff Specialists to be made aware and keep track of patients that might potentially require the intervention in order to reinforce the need to screen these patients for the study once the decision has been made.

Informed consent to be enrolled in the study will be sought from the Person Responsible at the time of consent for the tracheostomy procedure in general.

Patients where consent has been obtained will be randomly assigned to either of the study groups by drawing the top envelope from a stack of 50 (25 randomly allocated for each group - randomisation as per CONSORT guidelines). The envelopes will be identical and will not allow identification of the group allocation until they are opened.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/04/2011
Actual
23/08/2011
Date of last participant enrolment
Anticipated
Actual
6/07/2012
Date of last data collection
Anticipated
Actual
Sample size
Target
50
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 2672 0
Royal Prince Alfred Hospital - Camperdown
Recruitment hospital [2] 2673 0
Nepean Hospital - Kingswood
Recruitment postcode(s) [1] 3660 0
2050

Funding & Sponsors
Funding source category [1] 258520 0
Charities/Societies/Foundations
Name [1] 258520 0
Australasian Society for Ultrasound in Medicine
Country [1] 258520 0
Australia
Primary sponsor type
Hospital
Name
Royal Prince Alfred Hospital
Address
Missenden Road
Camperdown, NSW 2050
Country
Australia
Secondary sponsor category [1] 257657 0
None
Name [1] 257657 0
Address [1] 257657 0
Country [1] 257657 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 260561 0
Sydney South West Area Health Service Human Research Ethics Committee (RPAH Zone) EC00113
Ethics committee address [1] 260561 0
Ethics committee country [1] 260561 0
Australia
Date submitted for ethics approval [1] 260561 0
17/01/2011
Approval date [1] 260561 0
09/02/2011
Ethics approval number [1] 260561 0
Reference number: X11-0014 & HREC/11/RPAH/17

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 32227 0
Dr Mate Rudas
Address 32227 0
Intensive Care Services
Royal Prince Alfred Hospital
Missenden Road, Camperdown
NSW 2050 Australia
Country 32227 0
Australia
Phone 32227 0
+61295157668
Fax 32227 0
Email 32227 0
[email protected]
Contact person for public queries
Name 15474 0
Mate Rudas
Address 15474 0
Intensive Care Services
Royal Prince Alfred Hospital
Missenden Road, Camperdown
NSW 2050 Australia
Country 15474 0
Australia
Phone 15474 0
+61 2 9515 5513
Fax 15474 0
+61 2 9515 4373
Email 15474 0
[email protected]
Contact person for scientific queries
Name 6402 0
Mate Rudas
Address 6402 0
Intensive Care Services
Royal Prince Alfred Hospital
Missenden Road, Camperdown
NSW 2050 Australia
Country 6402 0
Australia
Phone 6402 0
+61 2 9515 5513
Fax 6402 0
+61 2 9515 4373
Email 6402 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.